Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective.
Gihan Hamdy ElsisiMariam Mohamed El-AttarShaimaa Mohamed IsmaeilMohamed El-Saeed El-ShaterMary G KirollosAmal S SedrakHany MoradHeba Abdel-MohsenMohamed Abdel-AzizMohamed MagdyOsama LoutfyPublished in: Global journal on quality and safety in healthcare (2023)
Metastatic prostate cancer has a huge economic burden on the Egyptian healthcare system compared with localized prostate cancer owing to the increased costs of progression, follow-up, and productivity loss. This highlights the necessity of early treatment of these patients to save costs and lighten the burden of the disease on the patient, society, and economy.